See the DrugPatentWatch profile for Savella
Information regarding Savella at a 25 mg dosage is limited. Savella (milnacipran hydrochloride) is typically prescribed in dosages of 50 mg twice daily, with potential increases to 100 mg twice daily [1].
What is Savella used for?
Savella is a medication used to treat fibromyalgia [1]. Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory, and mood issues [2].
How does Savella work?
Savella is classified as a serotonin and norepinephrine reuptake inhibitor (SNRI) [1]. By inhibiting the reuptake of serotonin and norepinephrine, it is thought to increase the levels of these neurotransmitters in the brain. These neurotransmitters play a role in pain perception, mood, and other functions, and their modulation is believed to help manage fibromyalgia symptoms [1].
What are the common dosages for Savella?
The starting dose for Savella is typically 50 mg taken twice daily. After one week, the dose may be increased to 100 mg taken twice daily. In some cases, the dose can be further increased to 150 mg taken twice daily (a total of 300 mg per day) [1]. The 25 mg dosage is not standard for this medication.
What are the potential side effects of Savella?
Common side effects reported with Savella include nausea, headache, constipation, dizziness, insomnia, hyperhidrosis (excessive sweating), vomiting, and palpitations [1].
Are there any risks associated with Savella?
Like other SNRIs, Savella carries a risk of suicidal thoughts and behaviors, especially in young adults and children. It also carries a risk of serotonin syndrome, a potentially life-threatening condition that can occur when serotonin levels become too high. Patients with certain pre-existing conditions, such as bipolar disorder or a history of seizures, should use Savella with caution [1].
When does the patent for Savella expire?
Information on the specific patent expiry dates for Savella is available through specialized drug patent databases [3]. These dates are crucial for understanding when generic versions of the medication may become available.
Who manufactures Savella?
Savella is manufactured by AbbVie Inc. [1].
How does Savella compare to other fibromyalgia treatments?
Other medications used to treat fibromyalgia include duloxetine and pregabalin, which are also FDA-approved for this condition [2]. The choice of medication often depends on individual patient response, tolerance to side effects, and other medical conditions.
Where can I find more information on drug patents?
For detailed information on drug patents, including those for Savella, resources such as DrugPatentWatch.com are available [3].
Sources:
[1] https://www.savella.com/
[2] https://www.mayoclinic.org/diseases-conditions/fibromyalgia/diagnosis-treatment/drc-20354785
[3] https://drugpatentwatch.com/